Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $19,540 | 8 | 53.6% |
| Food and Beverage | $11,373 | 424 | 31.2% |
| Travel and Lodging | $2,878 | 11 | 7.9% |
| Honoraria | $2,500 | 1 | 6.9% |
| Education | $154.03 | 33 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CHF Solutions, Inc | $25,805 | 34 | $0 (2020) |
| Nuwellis, Inc. | $2,782 | 6 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $1,229 | 59 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $770.82 | 39 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $744.66 | 36 | $0 (2024) |
| Amgen Inc. | $699.54 | 27 | $0 (2024) |
| Relypsa, Inc. | $657.57 | 47 | $0 (2020) |
| OPKO Pharmaceuticals, LLC | $613.15 | 75 | $0 (2024) |
| Vifor Pharma, Inc. | $455.05 | 25 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $366.91 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,979 | 94 | CALLIDITAS THERAPEUTICS US INC. ($316.08) |
| 2023 | $1,273 | 57 | Nuwellis, Inc. ($222.00) |
| 2022 | $721.33 | 36 | Fresenius USA Marketing, Inc. ($197.74) |
| 2021 | $3,269 | 63 | Nuwellis, Inc. ($2,560) |
| 2020 | $2,991 | 29 | CHF Solutions, Inc ($2,597) |
| 2019 | $7,600 | 62 | CHF Solutions, Inc ($6,478) |
| 2018 | $13,840 | 67 | CHF Solutions, Inc ($13,036) |
| 2017 | $4,773 | 69 | CHF Solutions, Inc ($3,694) |
All Payment Transactions
477 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Nephrology | ||||||
| 12/17/2024 | Cycle Pharmaceuticals Inc | Tiopronin (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: UROLOGY | ||||||
| 12/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/09/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $31.17 | General |
| Category: CRITICAL CARE | ||||||
| 11/26/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Nephrology | ||||||
| 11/19/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: NEPHROLOGY | ||||||
| 11/18/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $122.62 | General |
| Category: Nephrology | ||||||
| 11/18/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/07/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $121.60 | General |
| Category: Nephrology | ||||||
| 11/05/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $35.87 | General |
| Category: CRITICAL CARE | ||||||
| 11/04/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: NEPHROLOGY | ||||||
| 10/31/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: NEPHROLOGY | ||||||
| 10/31/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $4.72 | General |
| Category: NEPHROLOGY | ||||||
| 10/31/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $0.78 | General |
| Category: NEPHROLOGY | ||||||
| 10/30/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Nephrology | ||||||
| 10/29/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Inflammation | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: NEPHROLOGY | ||||||
| 10/02/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $4.72 | General |
| Category: NEPHROLOGY | ||||||
| 09/25/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Education | In-kind items and services | $4.72 | General |
| Category: NEPHROLOGY | ||||||
| 09/18/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Nephrology | ||||||
| 09/16/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/04/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/13/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $27.10 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,747 | 3,265 | $555,624 | $283,570 |
| 2022 | 16 | 1,990 | 3,779 | $632,649 | $325,531 |
| 2021 | 16 | 2,284 | 4,511 | $787,176 | $426,149 |
| 2020 | 16 | 2,669 | 5,507 | $1.0M | $493,955 |
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 144 | 264 | $132,000 | $68,497 | 51.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 265 | 982 | $98,200 | $57,354 | 58.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 132 | 330 | $42,900 | $29,345 | 68.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 338 | 404 | $52,520 | $24,492 | 46.6% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 76 | 331 | $57,925 | $17,655 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 337 | 360 | $34,200 | $16,634 | 48.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 68 | 77 | $38,500 | $16,182 | 42.0% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 33 | 63 | $31,500 | $13,652 | 43.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 97 | 99 | $19,800 | $12,720 | 64.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 73 | 73 | $12,775 | $8,315 | 65.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 64 | 68 | $9,316 | $6,556 | 70.4% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2023 | 19 | 69 | $11,730 | $4,282 | 36.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 56 | 94 | $7,050 | $3,458 | 49.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 17 | $3,060 | $1,984 | 64.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 17 | $2,210 | $1,240 | 56.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $1,938 | $1,205 | 62.2% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 189 | 364 | $182,000 | $98,544 | 54.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 298 | 1,052 | $105,200 | $56,205 | 53.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 141 | 402 | $52,260 | $31,317 | 59.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 328 | 417 | $48,594 | $25,357 | 52.2% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 43 | 95 | $47,500 | $21,412 | 45.1% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 107 | 321 | $56,175 | $17,804 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 433 | 476 | $35,095 | $17,298 | 49.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 105 | 111 | $21,670 | $15,851 | 73.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 51 | 55 | $27,500 | $12,345 | 44.9% |
About James Smelser, M. D
James Smelser, M. D is a Nephrology healthcare provider based in Huntsville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1881685089.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, James Smelser, M. D has received a total of $36,445 in payments from pharmaceutical and medical device companies, with $1,979 received in 2024. These payments were reported across 477 transactions from 41 companies. The most common payment nature is "Consulting Fee" ($19,540).
As a Medicare-enrolled provider, Smelser has provided services to 8,690 Medicare beneficiaries, totaling 17,062 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Huntsville, AL
- Active Since 11/04/2005
- Last Updated 09/13/2023
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1881685089
Products in Payments
- Aquadex (Device) $25,805
- AQUADEX SMARTFLOW CONSOLE (Device) $2,560
- Veltassa (Drug) $1,082
- JYNARQUE (Drug) $739.42
- Velphoro (Drug) $514.09
- SAMSCA (Drug) $504.84
- Parsabiv (Biological) $441.23
- RAYALDEE (Drug) $394.20
- TARPEYO (Drug) $366.91
- LOKELMA (Drug) $321.46
- FARXIGA (Drug) $253.70
- Aquadex Smartflow Console (Device) $222.00
- Kerendia (Drug) $206.18
- Rayaldee (Drug) $206.18
- INJECTAFER (Drug) $181.94
- BENLYSTA (Biological) $162.31
- Vafseo (Drug) $122.62
- XPHOZAH 30 MG (Drug) $121.19
- ACTHAR (Biological) $119.99
- KORSUVA (Drug) $109.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Huntsville
Michael Quadrini, M.d, M.D
Nephrology — Payments: $633,700
Mr. Dave Khurana, Md, MD
Nephrology — Payments: $10,879
Sayed Tabatabai, M.d, M.D
Nephrology — Payments: $7,455
Dr. Todd Broome, Md, MD
Nephrology — Payments: $6,979
Dr. David Tietjen, Md, MD
Nephrology — Payments: $5,751
Elisabeth Owen, Crnp, CRNP
Nephrology — Payments: $4,691